X-3010084-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1
The NM_001011719.2(ARSH):c.147C>T(p.Leu49Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0607 in 1,209,085 control chromosomes in the GnomAD database, including 1,709 homozygotes. There are 23,970 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.045 ( 116 hom., 1430 hem., cov: 22)
Exomes 𝑓: 0.062 ( 1593 hom. 22540 hem. )
Consequence
ARSH
NM_001011719.2 synonymous
NM_001011719.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.24
Genes affected
ARSH (HGNC:32488): (arylsulfatase family member H) Sulfatases, such as ARSH, hydrolyze sulfate esters from sulfated steroids, carbohydrates, proteoglycans, and glycolipids. They are involved in hormone biosynthesis, modulation of cell signaling, and degradation of macromolecules (Sardiello et al., 2005 [PubMed 16174644]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant X-3010084-C-T is Benign according to our data. Variant chrX-3010084-C-T is described in ClinVar as [Benign]. Clinvar id is 558976.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chrX-3010084-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.24 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0664 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARSH | NM_001011719.2 | c.147C>T | p.Leu49Leu | synonymous_variant | 2/9 | ENST00000381130.3 | NP_001011719.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARSH | ENST00000381130.3 | c.147C>T | p.Leu49Leu | synonymous_variant | 2/9 | 1 | NM_001011719.2 | ENSP00000370522.3 |
Frequencies
GnomAD3 genomes AF: 0.0452 AC: 5037AN: 111542Hom.: 116 Cov.: 22 AF XY: 0.0424 AC XY: 1430AN XY: 33708
GnomAD3 genomes
AF:
AC:
5037
AN:
111542
Hom.:
Cov.:
22
AF XY:
AC XY:
1430
AN XY:
33708
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0466 AC: 8538AN: 183277Hom.: 177 AF XY: 0.0486 AC XY: 3291AN XY: 67721
GnomAD3 exomes
AF:
AC:
8538
AN:
183277
Hom.:
AF XY:
AC XY:
3291
AN XY:
67721
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0623 AC: 68413AN: 1097487Hom.: 1593 Cov.: 30 AF XY: 0.0621 AC XY: 22540AN XY: 362945
GnomAD4 exome
AF:
AC:
68413
AN:
1097487
Hom.:
Cov.:
30
AF XY:
AC XY:
22540
AN XY:
362945
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0451 AC: 5034AN: 111598Hom.: 116 Cov.: 22 AF XY: 0.0423 AC XY: 1430AN XY: 33774
GnomAD4 genome
AF:
AC:
5034
AN:
111598
Hom.:
Cov.:
22
AF XY:
AC XY:
1430
AN XY:
33774
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | May 10, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at